At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
RSLS ReShape Lifesciences, Inc.
Market Closed 05-31 16:00:00 EDT
0.2549
+0.0048
+1.92%
盘后0.2499
-0.0050-1.96%
19:59 EDT
High0.2600
Low0.2121
Vol4.59M
Open0.2230
D1 Closing0.2501
Amplitude19.15%
Mkt Cap5.98M
Tradable Cap5.30M
Total Shares23.46M
T/O1.07M
T/O Rate22.10%
Tradable Shares20.79M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Semler Scientific, Genetic Technologies, ReShape Lifesciences among healthcare movers
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.